Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.

Filippi A, Ciolac OA, Ganea C, Mocanu MM.

J Oncol. 2017;2017:1532534. doi: 10.1155/2017/1532534. Review.

2.

Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements.

Yue Q, Gao G, Zou G, Yu H, Zheng X.

Biomed Res Int. 2017;2017:8412508. doi: 10.1155/2017/8412508. Review.

3.

Unraveling the Anticancer Effect of Curcumin and Resveratrol.

Pavan AR, Silva GD, Jornada DH, Chiba DE, Fernandes GF, Man Chin C, Dos Santos JL.

Nutrients. 2016 Nov 10;8(11). pii: E628. Review.

4.

Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?

Hessmann E, Johnsen SA, Siveke JT, Ellenrieder V.

Gut. 2017 Jan;66(1):168-179. doi: 10.1136/gutjnl-2016-312539. Review.

5.

Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation.

Lee HY, Kim SW, Lee GH, Choi MK, Jung HW, Kim YJ, Kwon HJ, Chae HJ.

BMC Complement Altern Med. 2016 Aug 26;16(1):316. doi: 10.1186/s12906-016-1307-6.

6.

Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment.

Polireddy K, Chen Q.

J Cancer. 2016 Jul 7;7(11):1497-514. doi: 10.7150/jca.14922. Review.

7.

Curcumin AntiCancer Studies in Pancreatic Cancer.

Bimonte S, Barbieri A, Leongito M, Piccirillo M, Giudice A, Pivonello C, de Angelis C, Granata V, Palaia R, Izzo F.

Nutrients. 2016 Jul 16;8(7). pii: E433. doi: 10.3390/nu8070433. Review.

8.

Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence.

Kotecha R, Takami A, Espinoza JL.

Oncotarget. 2016 Aug 9;7(32):52517-52529. doi: 10.18632/oncotarget.9593. Review.

9.

The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer.

Parsons HA, Baracos VE, Hong DS, Abbruzzese J, Bruera E, Kurzrock R.

Oncotarget. 2016 Apr 12;7(15):20293-304. doi: 10.18632/oncotarget.7773.

10.

Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.

Díaz Osterman CJ, Gonda A, Stiff T, Sigaran U, Valenzuela MM, Ferguson Bennit HR, Moyron RB, Khan S, Wall NR.

Pancreas. 2016 Jan;45(1):101-9. doi: 10.1097/MPA.0000000000000411.

11.

Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.

Osterman CJ, Lynch JC, Leaf P, Gonda A, Ferguson Bennit HR, Griffiths D, Wall NR.

PLoS One. 2015 Jul 15;10(7):e0132845. doi: 10.1371/journal.pone.0132845.

12.

Curcumin-encapsulated polymeric micelles suppress the development of colon cancer in vitro and in vivo.

Yang X, Li Z, Wang N, Li L, Song L, He T, Sun L, Wang Z, Wu Q, Luo N, Yi C, Gong C.

Sci Rep. 2015 May 18;5:10322. doi: 10.1038/srep10322.

13.

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.

James MI, Iwuji C, Irving G, Karmokar A, Higgins JA, Griffin-Teal N, Thomas A, Greaves P, Cai H, Patel SR, Morgan B, Dennison A, Metcalfe M, Garcea G, Lloyd DM, Berry DP, Steward WP, Howells LM, Brown K.

Cancer Lett. 2015 Aug 10;364(2):135-41. doi: 10.1016/j.canlet.2015.05.005.

14.

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.

Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM.

Trials. 2015 Mar 24;16:110. doi: 10.1186/s13063-015-0641-1.

15.

Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers.

Kim EJ, Semrad TJ, Bold RJ.

Expert Opin Investig Drugs. 2015 Jun;24(6):781-94. doi: 10.1517/13543784.2015.1026963. Review.

16.

Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.

Rahmani AH, Al Zohairy MA, Aly SM, Khan MA.

Biomed Res Int. 2014;2014:761608. doi: 10.1155/2014/761608. Review.

17.

Therapeutic applications of curcumin for patients with pancreatic cancer.

Kanai M.

World J Gastroenterol. 2014 Jul 28;20(28):9384-91. doi: 10.3748/wjg.v20.i28.9384. Review.

18.

Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.

Yallapu MM, Khan S, Maher DM, Ebeling MC, Sundram V, Chauhan N, Ganju A, Balakrishna S, Gupta BK, Zafar N, Jaggi M, Chauhan SC.

Biomaterials. 2014 Oct;35(30):8635-48. doi: 10.1016/j.biomaterials.2014.06.040.

19.

Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.

Neureiter D, Jäger T, Ocker M, Kiesslich T.

World J Gastroenterol. 2014 Jun 28;20(24):7830-48. doi: 10.3748/wjg.v20.i24.7830. Review.

20.

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

Godwin P, Baird AM, Heavey S, Barr MP, O'Byrne KJ, Gately K.

Front Oncol. 2013 May 16;3:120. doi: 10.3389/fonc.2013.00120.

Supplemental Content

Support Center